In contrast, NEAT1 and MALAT1 had significantly higher expression levels in the NSCLC group than in the control group (P = 0.022 and 0.002, respectively, Figure 2A, Supplementary Table S2). Here, MALAT1 is linked to non-small cell lung carcinoma.